Latest News & Upcoming Events
AMD Experts Unveil Treatment Guidelines Consensus Paper
Group of optometric thought-leaders issue much-needed advice in response to startling AMD statistics.
Read Press ReleaseMacuLogix Announces Optometric Advisory Board
Seven industry leaders to provide strategic input on the AdaptDx and practical guidelines for AMD
Read Press ReleaseMacuLogix Announces Communication Guide for Eye Care Professionals
The document is a step-by-step communication guide for eye care professionals treating patients with AMD.
Read Press ReleaseMacuLogix Appoints Vice President of Sales
Armond Dantino joined MacuLogix as Vice President of Sales. He will be responsible for all direct sales and business development functions.
Read Press ReleaseMacuLogix Appoints William McPhee as New CEO
MacuLogix Board of Directors has appointed William McPhee as Chief Executive Officer of the company.
Read Press ReleaseMacuLogix Announces Collaboration with ALLDocs
MacuLogix Collaborates with ALLDocs to demonstrate clinical and financial impact of early AMD detection utilizing the AdaptDx.
Read Press ReleaseDr. Paul M. Karpecki Joins the MacuLogix Clinical Advisory Board
Leading clinician and teacher will provide guidance on professional education programs to increase early detection of AMD.
Read Press ReleaseMacuLogix Receives CE Mark for AdaptDx
Direct sales in Europe for clinical use in the early detection of age-related macular degeneration (AMD) will begin in 2016.
Read Press ReleaseMacuLogix Raises $5 Million in Series C Financing
Funding supports nationwide sales of AdaptDx for the early detection of macular degeneration.
Read Press ReleaseMacuLogix Adds Clinical Advisory Board Members
Leading optometrists are to provide crucial guidance to MacuLogix – the AMD Experts.
Read Press Release